IP Library › Granted Patent US 8,617,813
Granted Patent B2
US 8,617,813 · App. 13/332,800 · Granted Dec 31, 2013

Methods for modulating embryonic stem cell differentiation

Inventors: Minoru S. H. Ko (Cockeysville, MD); Geppino Falco (Rotondi, IT); Sung-Lim Lee (Gyeongsan, KR); Manuela Monti (Baltimore, MD); Ilaria Stanghellini (Baltimore, MD)
Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,617,813
App. No.
13/332,800
Granted
Dec 31, 2013
Kind
B2
Abstract

Described herein is Zscan4, a gene exhibiting 2-cell embryonic stage and embryonic stem cell specific expression. Identification of nine Zscan4 co-expressed genes is also described. Inhibition of Zscan4 expression inhibits the 2-cell to 4-cell embryonic transition and prevents blastocyst implantation, expansion and outgrowth. Provided herein are methods of inhibiting differentiation of a stem cell, promoting blastocyst outgrowth of embryonic stem cells and identifying a subpopulation of stem cells expressing Zscan4. Further described is the identification of Trim43 as a gene exhibiting morula-specific expression. Also provided are isolated expression vectors comprising a Zscan4 promoter, or a Trim43 promoter operably linked to a heterologous polypeptide and uses thereof. Further provided are transgenic animals comprising transgenes encoding marker proteins operably linked to Zscan4 and Trim43 promoters.

Claims (9)

1. An in vitro method of identifying a subpopulation of cultured human or mouse embryonic stem (ES) cells expressing Zscan4, comprising:

(a) transfecting a population of mouse or human ES cells with an expression vector comprising a Zscan4c promoter operably linked to a nucleotide sequence encoding a reporter, wherein the Zscan4c promoter is selected from group consisting of the nucleic acid sequence as set forth in nucleotides (i) 1-2540 of SEQ ID NO: 28, (ii) 1-2643 of SEQ ID NO: 28, (iii) 1-3250 of SEQ ID NO: 28 and (iv) 1-3347 of SEQ ID NO: 28; and

(b) identifying a subpopulation of cells that expresses the reporter gene indicating Zscan-4 is expressed in the subpopulation of stem cells.

2. The method of claim 1 , wherein the expression vector consists of the nucleotide sequence as set forth in SEQ ID NO: 28.

3. The method of claim 1 , wherein the reporter gene encodes a marker, enzyme, or fluorescent protein.

4. The method of claim 1 , wherein the expression vector is a viral vector.

5. The method of claim 1 , wherein the expression vector is a plasmid vector.

6. The method of claim 1 , wherein the population of embryonic stem cells are mouse embryonic stem cells.

7. The method of claim 1 , wherein the population of embryonic stem cells are human embryonic stem cells.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2011
From: KO, MINORU S.H.; FALCO, GEPPINO; LEE, SUNG-LIM; MONTI, MANUELA; STANGHELLINI, ILARIA
To: THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 027429/0149 →
Continuity (3)
Division 12529004
Provisional Application 60920215 · Mar 26, 2007
Related Publication 20120129161A1 · May 24, 2012